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Abstract
Background. The Patient-Rated Wrist Evaluation is a region-
specifi c, self-administered questionnaire consisting of a pain 
scale (PRWE-P) and a functional scale (PRWE-F), with the 
latter consisting of specifi c function (PRWE-SF) and usual 
function (PRWE-UF). The PRWE was cross-culturally 
adapted from the original English version by the Impairment 
Evaluation Committee, Japanese Society for Surgery of the 
Hand (JSSH). The purpose of this study was to test the reli-
ability, validity, and responsiveness of the Japanese version of 
PRWE (PRWE-J).
Methods. A consecutive series of 117 patients with wrist dis-
orders completed the PRWE-J, the JSSH version of the Dis-
abilities of the Arm, Shoulder, and Hand (DASH-JSSH) 
questionnaire and the 36-Item Short-Form Health Survey 
(SF-36). Of the 117 patients, 71 were reassessed for test–retest 
reliability 1 or 2 weeks later. Reliability was investigated by 
reproducibility and internal consistency. To analyze the valid-
ity, a factor analysis (principal axis factoring) of PRWE-J and 
correlation coeffi cients between PRWE-J and DASH-JSSH 
were obtained. Responsiveness was examined by calculating 
the standardized response mean (SRM) (mean change/SD) 
and effect size (mean change/SD of baseline value) after open 
surgery in 50 patients.
Results. Cronbach’s α coeffi cients for PRWE-P, PRWE-F, and 
PRWE were 0.90, 0.95, and 0.95, respectively. The intraclass 
correlation coeffi cients (ICCs) for the same were 0.86, 0.93, 
and 0.92, respectively. Unidimensionality of PRWE-P was con-
fi rmed. Bidimensionality of PRWE-F was confi rmed and sepa-
rated clearly into PRWE-SF and PRWE-UF. The correlation 
coeffi cients between PRWE-P and PRWE-F or DASH-JSSH 
were 0.63 or 0.63, respectively. The correlation coeffi cient 
between PRWE-F and DASH-JSSH was 0.80. The correlation 
coeffi cients between DASH-JSSH and PRWE-SF or 
PRWE-UF were 0.76 or 0.73, respectively. Moderate correla-
tion was observed in “physical functioning” for SF-36 and 
PRWE-SF (r = −0.46), PRWE-F (r = −0.46), or PRWE (r = 
−0.46). The SRMs/effect sizes of PRWE-P, PRWE-F, or PRWE 
were respectively excellent: 1.7/2.2, 1.2/1.3, 1.6/1.9.
Conclusions. The PRWE-J has evaluation capacities equiva-
lent to those of the original PRWE.
Introduction
Health measurement scales are important patient 
outcome tools to measure health status and evaluate 
medical intervention.1 The arthritis impact measure-
ment scale (AIMS) was developed in 19802 and has 
been used for rheumatoid arthritis and distal radius 
fracture after its revision. The AIMS covers physical, 
social, and emotional well-being and was designed as an 
indicator of the outcome of care for arthritic patients. 
The revised version is known as AIMS2 (AIMS 2nd 
version).3
On the other hand, several measures for the evalua-
tion of upper extremity function have been developed,4–8 
especially for patients with wrist and hand disorders. 
Some of them are disease-specifi c measures, such as the 
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Brigham and Women’s Carpal Tunnel Questionnaire5 or 
the Carpal Tunnel Syndrome Instrument.9,10 Others are 
joint-specifi c4 or region-specifi c6–8 measures. Especially 
for the wrist and hand region, the most commonly used 
outcome measures described in the literature11 are the 
Disabilities of the Arm, Shoulder, and Hand (DASH) 
questionnaire 6 and the Patient-Rated Wrist Evaluation 
questionnaire (PRWE).7 The PRWE score is the most 
responsive instrument for evaluating the outcome in 
patients with distal radius fractures, whereas the DASH 
score is the best instrument for evaluating patients with 
disorders involving multiple joints of the upper limb.11 
The PRWE questionnaire has been used for distal 
radius fracture,12 and now it is used for the trapezio-
metacarpal joint,13 scaphoid nonunion,14 proximal row 
carpectomy,15 and distal radioulnar joint.16 The PRWE 
is currently available in several versions, including North 
American French,17 Chinese,18 Hong-Kong,19 German,20 
and Swedish21 versions.
We, the Impairment Evaluation Committee of the 
Japanese Society for Surgery of the Hand (JSSH), have 
completed cross-cultural adaptation and development 
of the Japanese version of PRWE (PRWE-J). The 
purpose of this study was to test the reliability, validity, 
and responsiveness of the PRWE-J and to make the 
PRWE-J available for use in Japan.
Materials and methods
In accordance with published guidelines,22 we organized 
the PRWE-J committee, which consisted of translators, 
researchers, and a methodologist. Our mission was to 
adapt the PRWE culturally into Japanese, as was done 
for the DASH-JSSH.23,24
Adaptation process
The English version of the PRWE7 was translated into 
Japanese by two translators whose fi rst language is Japa-
nese. One of them had no medical background, and the 
other did. Their two “forward” translations were synthe-
sized into one after being reviewed and discussed by the 
committee. This Japanese version (prefi nal version) was 
translated back into English by two other translators 
whose fi rst language is English. Both of them were 
blinded to the concepts being investigated and had 
no medical background. After we compared these two 
back-translations with the original PRWE, we devel-
oped the PRWE-J (prefi nal version 2). Then we 
commenced the pilot test. After analyzing the pilot test 
data, we modifi ed the prefi nal version 2 of PRWE-J 
into a fi nal version. The fi nal PRWE-J version was 
then evaluated with regard to reliability, validity, and 
responsiveness.
PRWE questionnaire
The PRWE questionnaire7 contains two subscales: a 
pain scale (PRWE-P) and a functional scale (PRWE-F). 
The PRWE-P consists of fi ve items that have multiple-
choice responses, which are scored from 1 point (mildest 
pain) to 10 points (most severe pain). The pain score is 
calculated as the sum of the scores for the fi ve individual 
items.
The PRWE-F consists of a specifi c function scale 
(PRWE-SF) and a usual function scale (PRWE-UF). 
The answers are rated from 1 point (no diffi culty with 
the activity) to 10 points (cannot perform the activity at 
all). The PRWE-SF has six specifi c wrist functional 
activities and is calculated as the total sum of all six 
items. The PRWE-UF has four usual wrist functional 
activities and is calculated as the total sum of all four 
items. The overall score for PRWE-F was calculated as 
the sum of PRWE-SF and PRWE-UF divided by two. 
The total PRWE score is the sum of PRWE-P and 
PRWE-F.
Patients and setting
The study was conducted on a consecutive series of 117 
patients with a wrist or hand disorder seen on an out-
patient or inpatient basis in seven orthopedic surgery 
departments in Japan (Table 1). Exclusion criteria were 
that the patients were <16 years old and/or they had 
wrist disorders concomitantly with a forearm disorder. 
The mean ± SD age was 50.0 ± 18.7 years (range 16–84 
years).
The patients agreed to participate in this study. They 
answered the PRWE-J questionnaire, the JSSH version 
of the DASH (DASH-JSSH) questionnaire,23,24 the offi -
cial Japanese version of the 36-Item Short-Form Health 
Survey (SF-36; version 2.0),25 and the visual analogue 
scale (VAS) (0–10 scale) for pain. The data collected 
from the 117 patients were used as a baseline value. 
Among the 117 patients, the 71 who had no treatment 
(e.g., medication or rehabilitation) during the consecu-
tive visits were readministered the PRWE-J question-
naire 1 or 2 weeks later. Among them, 50 of the 70 
patients who underwent open surgery by six hand sur-
geons answered the PRWE-J and the DASH-JSSH 
questionnaires twice: preoperatively and postopera-
tively 3 months after surgery.
Assessment of reliability, validity, and responsiveness
Reliability was investigated by looking at the reproduc-
ibility and internal consistency based on the test–retest 
method. The following analyses were conducted to 
examine the validity. A factor analysis (principal axis 
factoring) was conducted to examine the construct 
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validity and the unidimensionality of the PRWE-P 
and PRWE-F. Completeness of item responses of the 
PRWE-J was examined.
Correlation coeffi cients between the PRWE-P and 
PRWE-F and the DASH-JSSH were obtained. The 
following hypotheses were examined to investigate 
concurrent validity: (1) the PRWE-P would exhibit 
moderate association with DASH-JSSH; (2) the 
PRWE-F (SF and UF) would exhibit the strongest asso-
ciation with DASH-JSSH.
Correlation coeffi cients between the PRWE-P and 
PRWE-F and the SF-36 were also obtained. The follow-
ing hypotheses were examined to investigate concurrent 
validity: (1) the PRWE-P would exhibit the strongest 
association with “bodily pain” (SF-36-BP) among SF-36 
subscales; (2) the PRWE-F (SF and UF) would exhibit 
the strongest association with “physical functioning” 
(SF-36-PF) or “role-physical” (SF-36-RP). Those three 
subscales of SF-36 were chosen because the correlation 
between the DASH-JSSH and the three subscales of 
SF-36 was more than moderate.7
The responsiveness of both the PRWE-J and DASH-
JSSH were examined by calculating the standardized 
response mean (SRM) (mean change/SD)26 and effect 
size (mean change/SD of baseline value)27 after open 
surgery.
The protocol of this study was reviewed and approved 
by the institutional review board of Nippon Medical 
School prior to implementation.
Statistical analysis
Distribution of the PRWE-J, DASH-JSSH, SF-36, and 
VAS for pain, ages of the subjects, and time required to 
fi ll out the PRWE-J questionnaire were assessed. The 
interval measurements (PRWE-J, DASH-JSSH, all sub-
scales of SF-36 except physical functioning and age) 
were normally distributed; the other interval measure-
ments (physical functioning of SF-36, VAS for pain, and 
time required to fi ll out the PRWE-J questionnaire) 
were not normally distributed. Then, Cronbach’s α was 
used to assess the internal consistency of PRWE-J (P 
and F). The instrument test–retest reliability of PRWE-J 
(P and F) was assessed with the intraclass correlation 
coeffi cient (ICC). All correlation coeffi cients among the 
PRWE-J (P and F), DASH-JSSH, and SF-36 were cal-
culated with use of Spearman’s correlation (nonpara-
metric test) because some subscales of SF-36 were not 
normally distributed. Changes in measurement after 
carpal tunnel release were assessed with a parametric 
test (paired t-test). All statistical analyses were con-
ducted using the Statistical Package for Social Science 
Table 1. Descriptive summary of subjects
Parameter
Main morbidity 
(no.)
Co-morbidity 
(no.)
No. of subjects: 117 — —
Sex (M/F): 48/69 — —
Age (years), mean ± SD: 15–86 (50 ± 19) — —
Affected side (right/left): 62/52; both sides 3 — —
Hand dominancea (right/left): 108/3 — —
Diagnosis —
 Distal radius fracture 42 —
 Ulnocarpal abutment syndrome 16 —
 TFCC lesion 11 3
 Kienboeck’s disease 8 —
 Trapezio-metacarpal osteoarthritis 5 3
 Mid-carpal instability 5 —
 de Quervain’s disease 5 —
 Scaphoid fracture 4 —
 STT joint osteoarthritis 4 3
 Wrist ligament lesion 4 3
 Ganglion 4 —
 DRUJ arthritis 3 2
 Ulna styloid fracture 2 4
 Others 4 4
 Total 117 22
TFCC, triangular fi brocartilage complex; STT, scaphotrapezotrapezoidal; DRUJ, distal radioulnar 
joint
a Six patients had no record of hand dominance
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(SPSS) version 17.0.J software. The critical values for 
signifi cance were set at P < 0.05.
Results
Completeness of item responses
No patients had diffi culty completing the PRWE-J ques-
tionnaire. It took them 3 min 39 s, on average, to fi nish 
it (median 3 min 12 s; range 1–10 min). Most of the 
patients considered all the items to be clear. Of the 117 
patients, 4 did not answer one or more items. Among 
the four patients, one failed to answer four items and 
another failed to answer two items. Each of the other 
two patients failed to answer one item. The items that 
they failed to respond to were as follows: Item 4 of 
PRWE-P was left unanswered by two patients, items 4 
and 5 of PRWE-SF were each unanswered by one 
patient, item 3 of PRWE-UF was left unanswered by 
one patient, and item 4 of PRWE-UF was unanswered 
by three patients.
The mean, median, standard deviation, and range of 
the PRWE-J, DASH-JSSH, SF-36, and VAS for pain are 
shown in Table 2. Two, eight, and two patients had the 
minimum disability score of zero (ceiling) on the PRWE-
SF, PRWE-UF, and PRWE-F, respectively. A total of 5, 
26, 6, and 6 patients had a maximum disability score 
(fl oor) on the PRWE-P, PRWE-SF, PRWE-UF, and 
PRWE-F, respectively. No patients had a minimum or 
maximum disability score on the PRWE.
Reliability
Internal consistency was assessed by use of Cronbach’s 
α coeffi cient (Table 3). The α coeffi cient for the fi ve 
Table 2. Scores for PRWE, DASH, SF-36, and VAS
Instrumental scale No. Mean SD Median Minimum Maximum
PRWE-P 114 30.5 11.5 32 1 50b 
PRWE-SF 115 36.0 20.7 40 0a 60b 
PRWE-UF 112 20.6 12.1 22 0a 40b 
PRWE-F 112 28.2 15.4 29.5 0a 50b 
PRWE 112 58.7 24.3 61.5 5 99
DASH-JSSH 116 44.2 28.2 39.5 0a 100b 
SF36-PF_N 111 37.9 18.4 44.6 −11.8 58.7 
SF36-RP_N 114 30.0 16.7 29.0 1.7 56.2 
SF36-BP_N 114 36.7 10.5 35.3 17.2 61.4 
SF36-GH_N 113 49.1 9.0 48.9 28.9 69.4 
SF36-VT_N 113 47.4 10.0 47.2 19.5 68.7 
SF36-SF_N 114 43.0 13.9 43.9 4.5 57.1 
SF36-RE_N 114 37.0 16.7 39.6 5.6 56.6 
SF36-MH_N 112 44.4 11.1 43.8 14.6 65.1 
VAS 111 59.3 24.3 60 6 100b
PRWE-P, pain scale of the Japanese version of the Patient-Rated Wrist Evaluation (PRWE-J); 
SF, Specifi c Functional scale; UF, Usual Functional scale; F, Functional Scale
DASH-JSSH, Disability/Symptom scale of the Japanese version of the Disabilities of the Arm, 
Shoulder, and Hand (DASH) questionnaire
SF-36-PF_N, Standardized Physical Functioning subscale of the 36-Item Short-Form Health 
Survey (SF-36); RP_N, Standardized Role–physical subscale; BP_N, Standardized Bodily Pain 
subscale; GH_N, Standardized General Health subscale; VT_N, Standardized Vitality subscale; 
SF_N, Standardized Social Functioning subscale; RE_N, Standardized Role–emotional subscale; 
MH_N, Standardized Mental Health subscale
VAS, visual analogue scale for pain (0–10 scale)
a Maximum health status scores (ceiling)
b Minimum health status scores (fl oor)
Table 3. Internal consistency
Instrument scale No. Cronbach’s α Cronbach’s α range
PRWE-P 114 0.90 0.86–0.91
PRWE-SF 115 0.96 0.94–0.96
PRWE-UF 112 0.92 0.87–0.91
PRWE-F 111 0.95 0.94–0.95
PRWE 110 0.95 0.95–0.95
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items in the PRWE-P was 0.90 (n = 114); and when 
calculated for each of the fi ve items by eliminating each 
item one by one, the range was 0.86–0.91. The α coef-
fi cient for the six items in the PRWE-SF was 0.96 (n = 
115); and after eliminating one by one, the range was 
0.94–0.96. The α coeffi cient for the four items in the 
PRWE-UF was 0.92 (n = 112); and after eliminating one 
by one, the range was 0.87–0.91. The α coeffi cient for 
the 10 items in the PRWE-F was 0.95 (n = 111); and after 
elimination one by one, the range was 0.94–0.95. The α 
coeffi cient for the 10 items in the PRWE was 0.95 
(n = 110); and after eliminating one by one, the range 
was 0.95–0.95. In all of the above, no items were found 
to change the internal consistency substantially.
Instrument test–retest reliability was assessed with 
the intraclass correlation coeffi cient (ICC) (Table 4). 
There were 69 of 71 patients for the test–retest reliabil-
ity who had no missing items, and the period between 
the fi rst and second tests was a mean of 8.0 ± 3.5 days 
(range 1–18 days). The ICCs for the PRWE-P, PRWE-F, 
and PRWE were 0.86 [95% confi dence interval (CI) 
0.77–0.91], 0.93 (95% CI 0.88–0.96), and 0.92 (95% CI 
0.88–0.95), respectively. All ICCs for the PRWE-J sub-
scales and total scale indicate suffi cient reproducibility.
Validity
A factor analysis (principal axis factoring) was con-
ducted to confi rm the unidimensionality of the PRWE-P 
and PRWE-F. The fi rst factor of the PRWE-P had an 
eigenvalue (amount of variation in the total sample 
accounted for by that factor) 24 of 3.60, which explained 
the 72% total variance of the PRWE-P scores (Fig. 1). 
The unidimensionality of the PRWE-P was found to be 
strong as a result of the low eigenvalue of the second 
factor (0.55) (Fig. 1). When looking at the fi rst factor 
loading for each item, all items had loading of 0.4 or 
higher (Table 5).
The fi rst factor of the PRWE-F had an eigenvalue of 
7.06, which explained the 71% total variance of the 
PRWE-F scores (Fig. 2). The second factor of the 
PRWE-F had an eigenvalue of 1.16, which explained 
the 12% total variance of the PRWE-F scores and 
resulted in explaining 82% cumulative of PRWE-F 
scores (Fig. 2). The third factor of the PRWE-F had an 
Table 4. Intraclass correlation coeffi cient of PRWE
Instrument scale No. ICC 95% CI
PRWE-P 69 0.86 0.77–0.91
PRWE-SF 69 0.90 0.84–0.94
PRWE-UF 67 0.94 0.90–0.96
PRWE-F 67 0.93 0.88–0.96
PRWE 67 0.92 0.88–0.95
ICC, intraclass correlation coeffi cient; CI, confi dence interval
Fig. 1. Scree plot of the Patient-Rated Wrist Evaluation, Pain 
Scale (PRWE-P) factors
Table 5. Component matrix of factor analysis for PRWE-P
Item Component
Pain-1 0.73
Pain-2 0.91
Pain-3 0.87
Pain-4 0.87
Pain-5 0.84
Fig. 2. Scree plot of the PRWE-F (where F represents the 
Functional Scale) factors
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eigenvalue of 0.44, which explained the 4% total 
variance of the PRWE-F scores. A factor analysis indi-
cates two factors in the PRWE-F, which means the 
PRWE-F demonstrated a bidimensional structure.
When looking at the fi rst factor loading for each item, 
all items had loading of 0.4 or higher (Table 6). In addi-
tion, when looking at the second factor loading for each 
item, all items of specifi c function had minus values and 
all items of usual function had plus values (Table 6). This 
indicates that PRWE-F is composed of two types of 
item: specifi c function and usual function.
The correlation coeffi cients between the PRWE-P 
and the PRWE-F or the DASH-JSSH were 0.64 and 
0.63, respectively (Table 7) (P < 0.01). These results 
indicate moderate correlations between the PRWE-P 
and the PRWE-F and between the PRWE-P and the 
DASH-JSSH. The correlation coeffi cient between the 
PRWE-F and DASH-JSSH was 0.80 (Table 7) (P < 
0.01), which indicates a strong correlation between 
them. The correlation coeffi cients between the DASH-
JSSH and PRWE-SF or the PRWE-UF were 0.76 and 
0.73, respectively (Table 7) (P < 0.01). These results 
demonstrate strong correlations between the PRWE-SF 
and the DASH-JSSH as well as between the PRWE-UF 
and the DASH-JSSH and support the hypotheses set 
down in advance (Table 7).
The correlations between the PRWE-P score and the 
subscales of the SF-36 scale ranged from −0.24 to −0.37 
(Table 7). The strongest correlation was observed in 
“bodily pain.” The correlations between the PRWE-P 
and “bodily pain,” “role-physical,” and “physical func-
tioning” were somewhat weak. These results do not 
support the hypotheses set down in advance.
The correlations between the PRWE-SF score and 
the subscales of the SF-36 scale ranged from −0.16 to 
−0.46 (Table 7). A moderate correlation was observed 
in “physical functioning” and the PRWE-SF (r = −0.46), 
PRWE-F (r = −0.46) or PRWE (r = −0.46). These results 
support the hypotheses set down in advance (Table 7). 
The correlations between the PRWE-SF and “bodily 
pain” or “role-physical” in SF-36 were somewhat weak. 
These results do not support the hypotheses set down 
in advance.
The correlations between the PRWE-UF score and 
the subscales of the SF-36 scale ranged from −0.26 to 
−0.41 (Table 7). A moderate correlation was observed 
in the PRWE-UF and “physical functioning,” “bodily 
pain,” and “role-physical” (r = −0.37, −0.40, and −0.40, 
respectively.). These results support the hypotheses set 
down in advance.
The correlation between the PRWE-P score and VAS 
for pain was moderate (r = 0.66), and the correlation 
between PRWE-F score and VAS for pain was moder-
ate (r = 0.64) (Table 7).
Table 6. Component matrix of factor analysis for PRWE-F
Item
Component
1 2
SF-1 0.90 −0.22
SF-2 0.91 −0.21
SF-3 0.88 −0.17
SF-4 0.83 −0.34
SF-5 0.82 −0.29
SF-6 0.89 −0.28
UF-1 0.84 0.35
UF-2 0.82 0.45
UF-3 0.72 0.55
UF-4 0.80 0.33
SF, Specifi c Functional scale of PRWE-J; UF, Usual Functional scale 
of PRWE-J
Table 7. Correlation of PRWE, DASH, SF-36, and VAS
Instrument scale No.
Spearman’s correlation 
PRWE-P PRWE-SF PRWE-UF PRWE-F PRWE DASH
PRWE-P 114
PRWE-SF 113 0.59**
PRWE-UF 110 0.61** 0.76**
PRWE-F 110 0.64** 0.96** 0.91**
PRWE 110 0.78** 0.92** 0.89** 0.97**
DASH 113 0.63** 0.76** 0.73** 0.80** 0.81**
SF36-PF_N 112 −0.35** −0.46** −0.37** −0.46** −0.46** −0.59** 
SF36-RP_N 112 −0.28** −0.35** −0.40** −0.38** −0.36** −0.52**
SF36-BP_N 111 −0.37** −0.33** −0.40** −0.36** −0.37** −0.43**
SF36-GH_N 111 −0.35** −0.16 −0.26** −0.21* −0.26** −0.20*
SF36-VT_N 112 −0.32** −0.35** −0.35** −0.39** −0.39** −0.46**
SF36-SF_N 112 −0.30** −0.38** −0.41** −0.44** −0.42** −0.56**
SF36-RE_N 110 −0.26** −0.34** −0.41** −0.38** −0.36** −0.50**
SF36-MH_N 109 −0.24* −0.36** −0.34** −0.39** −0.36** −0.46**
VAS 114 0.66** 0.61** 0.61** 0.64** 0.70** 0.56**
*P < 0.05; **P < 0.01
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A multiple regression analysis of PRWE adjusted by 
age and sex was conducted because a statistical differ-
ence (P = 0.002) in age was found between means ± SD 
for men (43 ± 18 years) and women (54 ± 18 years). The 
PRWE scores were explained by the DASH score and 
VAS for pain (Table 8).
Responsiveness
Among the 70 patients who underwent open surgery, 50 
completed the PRWE and the DASH-JSSH at 3 months 
(mean ± SD 105 ± 25 days) after the surgery. The mean 
age of the subjects was 62 ± 14 years (range 21–86 
years). There were 20 men and 30 women. The calcu-
lated SRMs and effect sizes of PRWE-P, PRWE-SF, 
PRWE-UF, PRWE (n = 50), and DASH-JSSH (n = 50) 
were 1.73/2.18, 1.13/1.29, 1.13/1.19, 1.55/1.92, and 
1.30/1.20, respectively (Table 9). There were statistically 
signifi cant differences between the mean value of pre-
operative and postoperative PRWE-P, PRWE-SF, 
PRWE-UF, PRWE and DASH-JSSH (n = 50).
Among those subjected to the surgery, 24 of 50 had 
distal radius fractures. The calculated SRMs and effect 
sizes of PRWE-P, PRWE-SF, PRWE-UF, PRWE, and 
DASH-JSSH were 1.81/2.05, 1.59/6.20, 1.50/1.75, 
1.90/3.32, and 2.13/2.05, respectively (Table 9). There 
Table 8. Multiple regression of PRWE
Parameter B SE B β P
95% CI of B
Lower Upper
Constant 29.71 12.02 0.02 5.81 53.62
Age 0.05 0.09 0.04 0.58 −0.13 0.23
Sex −1.40 3.00 −0.03 0.64 −7.37 4.56
DASH 0.54 0.07 0.65 0 0.39 0.68
SF36-PF_N 0.02 0.10 0.02 0.81 −0.18 0.23
SF36-RP_N 0.11 0.15 0.08 0.49 −0.20 0.41
SF36-BP_N −0.21 0.19 −0.09 0.26 −0.59 0.16
SF36-GH_N −0.27 0.18 −0.11 0.13 −0.62 0.08
SF36-VT_N −0.13 0.26 −0.05 0.62 −0.64 0.38
SF36-SF_N 0.14 0.15 0.08 0.38 −0.17 0.44
SF36-RE_N 0.13 0.17 0.09 0.44 −0.20 0.46
SF36-MH_N −0.07 0.23 −0.03 0.76 −0.54 0.39
VAS 0.36 0.07 0.35 0 0.22 0.50
R2 = 0.74 (n = 99)
B, unstandardized coeffi cient; SE B, standard error of B
Table 9. Standardized response means and effect size of PRWE and DASH
Instrument scale
Total Radius fracture
No. SRM Effect size No. SRM Effect size
PRWE-P 50*** 1.73 2.18 24*** 1.81 2.05
PRWE-SF 50*** 1.13 1.29 24*** 1.59 6.20
PRWE-UF 50*** 1.13 1.19 24*** 1.50 1.75
PRWE-F 50*** 1.20 1.32 24*** 1.77 3.63
PRWE 50*** 1.55 1.92 24*** 1.90 3.32
DASH 50*** 1.30 1.20 24*** 2.13 2.05
SF36-PF_N 48*** −0.56 −0.54 24*** −0.80 −0.85
SF36-RP_N 49*** −0.67 −0.62 24*** −0.73 −0.71
SF36-BP_N 49*** −0.79 −0.95 24** −0.61 −0.67
SF36-GH_N 48 −0.16 −0.17 24 −0.43 −0.39
SF36-VT_N 49** −0.41 −0.50 24** −0.68 −0.94
SF36-SF_N 49*** −0.66 −0.72 24*** −1.04 −1.11
SF36-RE_N 49*** −0.75 −0.65 24*** −0.91 −0.77
SF36-MH_N 48*** −0.67 −0.69 24*** −0.75 −0.98
VAS 49*** 1.75 2.23 24*** 2.00 2.96
SRM, standardized response means
* Signifi cant difference between the preoperative and postoperative median values (P < 0.05)
** Signifi cant difference between the preoperative and postoperative median values (P < 0.01)
*** Signifi cant difference between the preoperative and postoperative median values (P < 0.001)
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were statistical differences between the mean values of 
preoperative and postoperative PRWE-P, PRWE-SF, 
PRWE-UF, PRWE, and DASH-JSSH (n = 24).
Discussion
The original PRWE questionnaire was cross-culturally 
adapted into Japanese in accordance with a systematic 
standardized approach.23 The purpose of this study was 
to examine the psychometric qualities of the PRWE-J 
by assessing its psychometric standards in the areas of 
reliability, validity, and responsiveness.
The PRWE consists of a 5-item pain scale and a 
10-item functional scale. It took patients a shorter 
amount of time to complete the PRWE-J than to com-
plete the DASH-JSSH.24 The amount of time to com-
plete the PRWE-J was equivalent to the time to complete 
the North American French version of PRWE (3 min, 
range 5–7 min).17 This indicated that the questionnaire 
was easy to understand. Whereas the DASH-JSSH has 
ceiling and fl oor effects, a lack of both of these effects 
in the PRWE-J ensures the validity of both subscales of 
PRWE-J.
Internal consistency was assessed by use of Cron-
bach’s α coeffi cient (Table 3). The α coeffi cients for 
pain, specifi c function, usual function, and total scores 
in PRWE-J (0.90/0.96/0.92/0.95) were equivalent to 
those of the original version (0.93/0.96/0.92/0.98),28 the 
Chinese version (0.94/0.94/0.97/0.98),18 and the German 
version (0.81/–/–/0.89).29
Instrument test–retest reliability was assessed with 
the ICC (Table 4). The ICCs of the pain, specifi c func-
tion, usual function, and total scores in PRWE-J 
(0.86/0.90/0.94/0.92) were equivalent to those of the 
original version (0.90/0.93/0.92/0.94),28 the Chinese 
version (0.91/0.90/0.88/0.93),18 and the German version 
(0.86/–/–/0.94).29 This indicates that the ICCs for the 
PRWE-J subscales and total scale have suffi cient 
reproducibility.
The validation process of the PRWE-J questionnaire 
has shown that it has validity similar to those of the 
Swedish version22 and the original PRWE.28 The strong 
correlations between the PRWE-J and DASH-JSSH 
support this validity (Table 7). The weak correlations 
between the PRWE-J and SF-36 failed to demonstrate 
this validity, although the bodily pain and physical func-
tioning of SF-36 have moderate correlation with the 
German version29 as well as the original PRWE.28 
DASH-JSSH has higher correlations with the bodily 
pain and physical functioning of SF-36 than PRWE-J. 
This is thought to be because the DASH deals with a 
broader region of the whole body than the PRWE. 
These results demonstrated that the PRWE-J measures 
only one area of health-related quality of life.
The pain scale of PRWE-J exhibited high unidimen-
sionality (Table 5, Fig. 1), and there was no low item–
scale correlation. The loading of this scale was very high. 
These results show that the pain scale of PRWE-J has a 
high quality of validation.
The functional scale of PRWE exhibited bidimen-
sionality (Table 6, Fig. 2). The two factors could be 
clearly separated into specifi c function and usual func-
tion. This means that the functional scale of PRWE-J 
has a high quality of validation.
Cohen’s rule-of-thumb for interpreting the “effect 
size index” (a value of 0.2 is small, 0.5 is moderate, and 
≥0.8 is large) can be applied to the SRM.26 The respon-
siveness (SRM/ES) of the pain scale and functional 
scale of the PRWE-J for the patients overall were excel-
lent 3 months after operation and were larger than 
those of the DASH-JSSH. The responsiveness of the 
pain scale and functional scale of the PRWE-J for 
patients with a distal radius fracture were equivalent to 
the results 3 months after operation.
We believe the strengths of this study are that 
the PRWE-J demonstrated good reproducibility, 
consistency, and validity. Moreover, it had good 
responsiveness.
Conclusions
We concluded that the Japanese version of PRWE 
(PRWE-J) has evaluation capacities comparable to 
those of the original PRWE. We expect that use of this 
scale in Japan for self-assessment by patients of treat-
ment will contribute to meaningful improvement of out-
comes for patients with wrist problems.
None of the authors of this manuscript has received any type 
of support, benefi ts, or funding from any commercial party 
related directly or indirectly to the subject of this article.
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